Abstract
The COVID-19 pandemic has contributed to anxiety and depression in many communities across the United States. Here, we have focused on a sample of Houston-based Middle Eastern and North African (MENA) residents and assessed the prevalence of anxiety and depression in this community. The 7-item Generalized Anxiety Disorder and the 9-item Patient Health Questionnaires were used to identify the prevalence and severity of anxiety and depression, respectively. A sociodemographic, general health, and COVID-19 survey was used for a multivariable logistic regression model to determine predictors of anxiety and depression. The outcome of interest was “minimal/mild” versus “moderate/severe” anxiety and depression. A total of 368 participants completed the survey, with 24.73% reporting “moderate/severe” anxiety and 31.79% reporting “moderate/severe” depression. Male participants were less likely (OR = 0.29, 95% CI = 0.12, 0.75) to have “moderate/severe” anxiety compared to females. Respondents with self-reported depression were more likely (OR = 3.41, 95% CI = 1.33, 8.83) to have “moderate/severe” depression. Participants who reported having “Excellent/Good knowledge” about the prevention of COVID-19 spread were less likely (OR = 0.37, 95% CI = 0.15, 0.93) to have “moderate/severe” depression, and less likely (OR = 0.22, 95% CI = 0.07, 0.64) to have “moderate/severe” anxiety, compared to those who had “average/poor/terrible” knowledge. Identified predictors may be critical for designing culturally sensitive interventions to improve the healthcare of MENA Americans.
Reference43 articles.
1. Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health;Center for Behavioral Health Statistics and Quality,2015
2. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
3. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition
4. Features, evaluation, and treatment of coronavirus (COVID-19);Cascella,2022
5. Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic — United States, June 24–30, 2020